Development of a human iPSC line (SMBCi017-A) from a healthy donor

Zhenzhong Han(Shandong First Medical University), Jinxiang Han(Shandong First Medical University), Jing Luan(Fudan University), Jing Wang(Shanghai Jiao Tong University), Yazhou Cui(Shandong First Medical University)
Stem Cell Research
July 5, 2022
10.1016/j.scr.2022.102852
Cited by 1

Related Papers

Myc activates telomerase
|Genes & Development|1998|659
Glycolytic Enzymes Can Modulate Cellular Life Span
|Cancer Research|2005|640
Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing
|Genes & Development|2015|278
Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation
|Stem Cells|2015|189
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
|Genes|2016|151